Project Details
Description
A retrospective chart review study to assess the clinical outcome of triheptanoin treatment in patients with long-chain fatty acid oxidation disorders (LC-FAOD) treated under expanded access program
| Status | Finished |
|---|---|
| Effective start/end date | 11/29/18 → 11/29/20 |
Funding
- ULTRAGENYX PHARMACEUTICAL INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.